[go: up one dir, main page]

ATA152591A - Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen - Google Patents

Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen

Info

Publication number
ATA152591A
ATA152591A AT0152591A AT152591A ATA152591A AT A152591 A ATA152591 A AT A152591A AT 0152591 A AT0152591 A AT 0152591A AT 152591 A AT152591 A AT 152591A AT A152591 A ATA152591 A AT A152591A
Authority
AT
Austria
Prior art keywords
compositions
producing
deliver substances
deliver
substances
Prior art date
Application number
AT0152591A
Other languages
English (en)
Other versions
AT396425B (de
Inventor
Jean-Marc Ruiz
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of ATA152591A publication Critical patent/ATA152591A/de
Application granted granted Critical
Publication of AT396425B publication Critical patent/AT396425B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0152591A 1990-08-01 1991-07-31 Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen AT396425B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA152591A true ATA152591A (de) 1993-01-15
AT396425B AT396425B (de) 1993-09-27

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0152591A AT396425B (de) 1990-08-01 1991-07-31 Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen

Country Status (30)

Country Link
US (1) US5213812A (de)
JP (1) JP2818704B2 (de)
KR (1) KR920003962A (de)
AT (1) AT396425B (de)
AU (2) AU649696B2 (de)
BE (1) BE1004772A3 (de)
CA (1) CA2048270C (de)
CH (1) CH682715A5 (de)
DE (1) DE4125542A1 (de)
DK (1) DK175756B1 (de)
ES (1) ES2046083B1 (de)
FI (1) FI104149B1 (de)
FR (1) FR2665360B1 (de)
GB (1) GB9016885D0 (de)
GR (1) GR1001512B (de)
HK (1) HK33294A (de)
IE (1) IE65124B1 (de)
IN (1) IN178446B (de)
IT (1) IT1251788B (de)
LU (1) LU87982A1 (de)
MA (1) MA22245A1 (de)
MY (1) MY107500A (de)
NL (1) NL194637C (de)
NO (1) NO300158B1 (de)
NZ (1) NZ238981A (de)
OA (1) OA09387A (de)
PT (1) PT98497B (de)
SE (1) SE505734C2 (de)
TN (1) TNSN91067A1 (de)
ZA (1) ZA915565B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
EP0740548B1 (de) * 1994-02-28 2002-12-04 Nanopharm AG System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
EP0930874A2 (de) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. Herstellungsverfahren für mikropartikel
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
AU3555599A (en) 1998-04-13 1999-11-01 Luminex Corporation Liquid labeling with fluorescent microparticles
OA11728A (en) * 1998-12-16 2005-02-01 Aventis Pharma Inc Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same.
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
DK1418890T3 (da) * 2001-08-16 2008-08-11 Baxter Int Drivmiddel-baserede mikropartikelformuleringer
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
US8075919B2 (en) * 2003-07-18 2011-12-13 Baxter International Inc. Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
ES2313350T3 (es) 2004-05-12 2009-03-01 Baxter International Inc. Microesferas de acido nucleico, produccion y suministro de las mismas.
AU2005244840C1 (en) * 2004-05-12 2012-05-10 Baxter Healthcare S.A. Microspheres comprising protein and showing injectability at high concentrations of said agent
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
KR20070042177A (ko) * 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물의 조절 방출을 위한 세라믹 구조체
WO2006017336A2 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
WO2006050345A1 (en) * 2004-10-29 2006-05-11 Adhesives Research, Inc. Microscopic tagging system for security identification
AU2006241145B2 (en) * 2005-04-27 2011-04-28 Baxter Healthcare S. A. Surface-modified microparticles and methods of forming and using the same
EP1928814A2 (de) * 2005-08-23 2008-06-11 Altairnano, Inc Hoch photokatalytische phosphordotierte anatas-tio2-zusammensetzung und zugehörige herstellungsverfahren
WO2007103812A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for low temperature production of nano-structured iron oxide coatings
US20080044638A1 (en) * 2006-03-02 2008-02-21 Fred Ratel Nanostructured Metal Oxides
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
AU2007281737B2 (en) 2006-08-04 2013-09-19 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
EP2068845A2 (de) * 2006-10-06 2009-06-17 Baxter International Inc. Mikroverkapselungen mit oberflächenmodifizierten mikropartikeln sowie verfahren zu ihrer herstellung und verwendung
EP3590503A1 (de) 2006-10-12 2020-01-08 The University of Queensland Zusammensetzungen und verfahren zur modulation von immunreaktionen
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
JP5744513B2 (ja) * 2007-04-17 2015-07-08 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 肺送達のための核酸微小粒子
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
MX2010011508A (es) 2008-04-18 2011-05-03 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la nueva presentacion de diabetes autoinmune.
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US20100078848A1 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CA2762650A1 (en) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
US20110076771A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
EP2575773A4 (de) 2010-05-26 2014-06-25 Selecta Biosciences Inc Synthetische nanoträgerkombinationsimpfstoffe
EP2399931A1 (de) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Neue Oktapeptid-Verbindungen und ihr therapeutischer Einsatz
JP2013545453A (ja) 2010-11-01 2013-12-26 ユニバーシティ・オブ・テクノロジー、シドニー 免疫変調剤およびそれらの使用
WO2013019669A2 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
ES2936067T3 (es) 2014-05-27 2023-03-14 Univ Queensland IL-22 para uso en el tratamiento de trastornos metabólicos
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (de) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
FI104149B (fi) 1999-11-30
DK175756B1 (da) 2005-02-14
ZA915565B (en) 1992-04-29
DE4125542A1 (de) 1992-02-06
NZ238981A (en) 1992-11-25
FI913646L (fi) 1992-02-02
PT98497B (pt) 1997-10-31
US5213812A (en) 1993-05-25
GB9016885D0 (en) 1990-09-12
PT98497A (pt) 1992-06-30
CA2048270A1 (en) 1992-02-02
HK33294A (en) 1994-04-22
AU5939394A (en) 1994-06-02
IE912700A1 (en) 1992-02-12
IE65124B1 (en) 1995-10-04
AU666808B2 (en) 1996-02-22
FI104149B1 (fi) 1999-11-30
NO300158B1 (no) 1997-04-21
SE9102249D0 (sv) 1991-07-26
ES2046083B1 (es) 1994-08-01
OA09387A (fr) 1992-09-15
LU87982A1 (fr) 1992-04-15
IT1251788B (it) 1995-05-26
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
AT396425B (de) 1993-09-27
FR2665360A1 (fr) 1992-02-07
IN178446B (de) 1997-05-03
MY107500A (en) 1995-12-30
AU8146691A (en) 1992-02-06
NL9101306A (nl) 1992-03-02
ES2046083A1 (es) 1994-01-16
DK141891D0 (da) 1991-07-31
GR1001512B (el) 1994-02-28
JPH05178740A (ja) 1993-07-20
ITMI911953A1 (it) 1993-01-15
SE505734C2 (sv) 1997-10-06
CH682715A5 (fr) 1993-11-15
ITMI911953A0 (it) 1991-07-15
JP2818704B2 (ja) 1998-10-30
TNSN91067A1 (fr) 1992-10-25
SE9102249L (sv) 1992-02-02
DK141891A (da) 1992-02-02
KR920003962A (ko) 1992-03-27
NO912986D0 (no) 1991-07-31
FI913646A0 (fi) 1991-07-31
FR2665360B1 (fr) 1995-02-10
AU649696B2 (en) 1994-06-02
CA2048270C (en) 1997-02-25
MA22245A1 (fr) 1992-04-01
GR910100330A (en) 1992-08-31
BE1004772A3 (fr) 1993-01-26
NL194637C (nl) 2002-10-04

Similar Documents

Publication Publication Date Title
ATA152591A (de) Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen
DE69019570D1 (de) Verfahren und Vorrichtung zur Herstellung von dreidimensionalen Objekten.
DE69015489D1 (de) Dekorationsfilm und verfahren zur herstellung.
DE69110475D1 (de) Verfahren zur herstellung von perfluorolefinen.
DE69623567D1 (de) Verfahren und Vorrichtung zur Herstellung von Pulverpresslingen
DE69023410D1 (de) Verfahren und Vorrichtung zur Herstellung von Pellets.
DE59102342D1 (de) Vorrichtung und Verfahren zur Herstellung von Gussformteilen.
DE59002322D1 (de) Verfahren zur herstellung von 1,1,1,3,3,3-hexafluorpropan und 2-chlor-1,1,1,3,3,3-hexafluorpropan.
DE69109964D1 (de) Verfahren und Vorrichtung zur Herstellung von Sole.
DE69007418D1 (de) Octadienyläther und verfahren zur herstellung von octadienyläthern.
DE69106421D1 (de) Verfahren und Vorrichtung zur Herstellung von Metallpulver.
DE3874415D1 (de) Stranggepresster gegenstand und verfahren zur herstellung desselben.
DE69106370D1 (de) Verfahren zur herstellung von werkzeugen und matrizen.
DE69020135D1 (de) Konvergierender filter und verfahren zur herstellung.
DE59106553D1 (de) Verfahren zur herstellung von chlorfluornitrobenzolen und difluornitrobenzolen.
DE3885093D1 (de) Verfahren zur herstellung von teilförmigem metallpulver.
DE69128432D1 (de) Verfahren und vorrichtung zur herstellung von metallstäben
DE69022972D1 (de) Supraleitfähiges drahtmaterial und verfahren zur herstellung.
DE59006073D1 (de) Verfahren zur herstellung von azopigmenten.
DE69016460D1 (de) Verfahren zur herstellung von 2-ethylhexyl-para-methoxycinnamat.
DE69314480D1 (de) Verfahren zur herstellung von 1,1,1,2,2,4,4,5,5,5,-decafluorpentan
DE69224505D1 (de) Verfahren und vorrichtung zur herstellung von metallpulver
DE69011336D1 (de) Verfahren und vorrichtung zur herstellung von broschüren.
DE68914447D1 (de) Verfahren zur herstellung von teilchenpolymeren.
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee